Shareholders sued directors of Juul Labs in a superior court class action, claiming their abuse and aiding and abetting contributed to a $19 billion decline in the value of (nonparty) Altria Group, which had invested $12.8 billion in Juul.
Read moreDirectors are selling Tiffany & Co,, too cheaply through an unfair process to Moёt Hennessy-Louis Vuitton, for $135 a share or $14.5 billion, shareholders say in a federal class action.
Read moreA shareholder class action claims directors are selling the Craft Brew Alliance too cheaply through an unfair process to Anheuser-Busch, for $16.50 a share or $321 million, in King County Court.
Read moreA federal class action claims directors are selling ArQule (biopharmaceuticals) too cheaply through an unfair process to Merck Sharp & Dohme, for $20 a share or $2.7 billion.
Read moreThe Houston Municipal Employees Pension System filed a shareholder class action against Mattel, claiming its false financial statement for the third quarter of 2017 understated its net loss by more than $109 million, in federal court.
Read moreShareholders say in a federal class action that directors are selling Tech Data Corp. too cheaply through an unfair process to Apollo Global Management, for $145 per share or $5.1 billion.
Read moreA shareholder class action accusers directors of “a massive fraud that has left Akorn — a once-vibrant multibillion-dollar pharmaceutical company — in ruins,” in federal court.
Read more
Shareholders claim in a class action that Google’s $2.1 billion bid to acquire wearable fitness technology company Fitbit undervalues the company and came to fruition through an unfair process.
Read moreXL Specialty Insurance Co. claims in superior court that Starz Entertainment owes it $10 million for the $92.5 million shareholder class action settlement after Starz was purchased by Lions Gate.
Read moreShareholders claim in a federal class action that directors of The Medicines Company made false and misleading statements to support its sale to Novartis for $85 per share or $9.7 billion.
Read moreShareholders say in a federal class action that Fitbit issued a false and misleading proxy statement for its proposes $2.1 billion merger with Google, at $7.35 a share.
Read moreA federal class action claims Cayman Islands-based Cision Ltd. issued a false and misleading proxy statement regarding its $2.7 billion merger with co-defendant Platinum Equity Advisors, for $10 a share.
Read more
A cross-border securities class action against Canadian cannabis company HEXO Corp. alleges the company inflated revenue figures, misstated inventory, and grew cannabis in an unlicensed facility leading to hundreds of millions of dollars in market capitalization loss.
Read moreOnline food delivery service Grubhub faces a securities fraud class action after it reported deeply disappointing third quarter financial results, causing its share price to fall by nearly 40%.
Read more
Shareholders claim in a class action that in the lead-up to its initial public offering, Uber Technologies Inc. failed to warn investors about “rapidly increasing subsidies for customer rides and meals in a bid for market share” while “at the same time, cutting (or planning to cut) costs in key areas that undermined Uber’s central growth opportunities.”
Read moreA federal class action claims Ascendant Capital, GPB Holdings and 94 other entities ran a $1.8 billion Ponzi scam involving GPB Funds.
Read moreAmid power outages affecting 179,000 customers – and another one coming that could affect nearly 900,000 – Pacific Gas and Electric executives were hit with a federal class action Friday claiming they misled investors about the company’s preparedness for pre-emptive blackouts.
Read moreDirectors are selling Avon too cheaply through an unfair process to a newly formed Brazilian cosmetics company, Natura, in a cash and stock deal valued in the hundreds of millions, shareholders say in a class action in Kings County Court, N.Y.
Read moreDirectors are selling Pivotal Software too cheaply through an unfair process, for $15 a share or $2.7 billion, shareholders say in a federal class action.
Read moreA union pension fund claims in a shareholder class action that Chemours “concealed the true extent of the massive environmental liabilities the company incurred from decades of producing and releasing a variety of chemicals that have been linked to cancer and other serious health consequences by DuPont, Chemours’ former parent company prior to its spinoff, and by Chemours itself,” in federal court.
Read more